TI

Tonkawa Investments

Description

Tonkawa Investments operates as an investment firm.

Investor Profile

Tonkawa Investments has made 3 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (67%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
  • Health Care
  • Medical Device
  • Mobile Devices
  • Neuroscience
  • Wearables
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tonkawa Investments frequently co-invest with?

Shangbay Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Angelini Ventures
Europe, Lazio, Italy, Rome
Co-Investments: 1
Solas BioVentures
North America, Tennessee, United States, Chattanooga
Co-Investments: 2
JobsOhio
North America, Ohio, United States, Columbus
Co-Investments: 1
Asahi Kasei
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Coloplast
North America, Minnesota, United States, Minneapolis
Co-Investments: 2
Avestria Ventures
North America, California, United States, San Francisco
Co-Investments: 1
HV
North America, Tennessee, United States, Chattanooga
Co-Investments: 1
Medtronic
North America, Minnesota, United States, Minneapolis
Co-Investments: 1
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 3

What are some of recent deals done by Tonkawa Investments?

Francis Medical

Maple Grove, Minnesota, United States

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Medical
Series CJan 7, 2025
Amount Raised: $80,000,000
Avation Medical

Columbus, Ohio, United States

Avation Medical is pioneering new platforms for wearable nerve stimulation systems.

Health CareMedicalMedical DeviceMobile DevicesNeuroscienceWearables
Series CFeb 1, 2024
Amount Raised: $22,000,000
Francis Medical

Maple Grove, Minnesota, United States

Francis Medical is a medical technology company developing therapeutic solutions to treat prostate, kidney, and bladder cancer.

Medical
Series BSep 15, 2021
Amount Raised: $55,000,000